Improving risk stratification in patients with prostate cancer managed by active surveillance: nomogram predicting the risk of biopsy progression

被引：1
|
作者：
Marks, Leonard S. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
来源：
BJU INTERNATIONAL | 2014年 / 113卷 / 04期
关键词：
D O I：
10.1111/bju.12306
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E13 / E14
页数：2
相关论文
共 50 条
  • [41] Risk stratification: a tool to predict the course of active surveillance for localized prostate cancer?
    Herden, Jan
    Heidenreich, Axel
    Weissbach, Lothar
    BJU INTERNATIONAL, 2017, 120 (02) : 212 - 218
  • [42] Combined MRI-targeted Plus Systematic Confirmatory Biopsy Improves Risk Stratification for Patients Enrolling on Active Surveillance for Prostate Cancer
    O'Connor, Luke P.
    Wang, Alex Z.
    Yerram, Nitin K.
    Lebastchi, Amir H.
    Ahdoot, Michael
    Gurram, Sandeep
    Zeng, Johnathan
    Mehralivand, Sherif
    Harmon, Stephanie
    Merino, Maria J.
    Parnes, Howard L.
    Choyke, Peter L.
    Turkbey, Baris
    Wood, Bradford J.
    Pinto, Peter A.
    UROLOGY, 2020, 144 : 164 - 170
  • [43] Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance
    Robert R. Flavell
    Antonio C. Westphalen
    Carmin Liang
    Christopher C. Sotto
    Susan M. Noworolski
    Daniel B. Vigneron
    Zhen J. Wang
    John Kurhanewicz
    Abdominal Imaging, 2014, 39 : 1027 - 1035
  • [44] Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance
    Flavell, Robert R.
    Westphalen, Antonio C.
    Liang, Carmin
    Sotto, Christopher C.
    Noworolski, Susan M.
    Vigneron, Daniel B.
    Wang, Zhen J.
    Kurhanewicz, John
    ABDOMINAL IMAGING, 2014, 39 (05): : 1027 - 1035
  • [45] Stratification of risk for patients with prostate cancer at biopsy using CCP score
    Shore, Neal D.
    Abbott, Brian
    Concepcion, Raoul S.
    Saltzstein, Daniel
    Kaldate, Rajesh R.
    Moyes, Kelsey
    van Breda, Arletta
    Clark, Christopher
    Saam, Jennifer
    Brawer, Michael K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [46] Improving the stratification of intermediate risk prostate cancer
    Nocera, Luigi
    Ruvolo, Claudia Colla
    Stolzenbach, Lara F.
    Deuker, Marina
    Tian, Zhe
    Gandaglia, Giorgio
    Fossati, Nicola
    Abdollah, Firas
    Suardi, Nazareno
    Mirone, Vincenzo
    Graefen, Markus
    Chun, Felix K.
    Saad, Fred
    Montorsi, Francesco
    Briganti, Alberto
    Karakiewicz, Pierre I.
    MINERVA UROLOGY AND NEPHROLOGY, 2022, 74 (05): : 590 - 598
  • [47] Multiparametric magnetic resonance imaging in the active surveillance of prostate cancer: protocol, risk stratification, and surveillance
    Qin, Xiaoyan
    Lv, Jian
    Zhu, Xiqi
    JOURNAL OF MENS HEALTH, 2024, 20 (04) : 12 - 18
  • [48] THE TOTAL NUMBER OF POSITIVE CORES IN DIAGNOSTIC AND REPEAT BIOPSIES IS STRONGLY ASSOCIATED WITH THE RISK OF PROGRESSION IN PROSTATE CANCER PATIENTS MANAGED BY ACTIVE SURVEILLANCE
    Iremashvili, Viacheslav
    Manoharan, Murugesan
    Rosenber, Daniel L.
    Soloway, Mark S.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E283 - E284
  • [49] UTILITY OF SERIAL MRI/ULTRASOUND FUSION TARGETED BIOPSY IN MEN WITH LOW RISK PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE
    Hsiang, Walter
    Ghabili, Kamyar
    Lu, Amanda
    Syed, Jamil
    Nguyen, Kevin
    Suarez-Sarmiento, Alfredo
    Leapman, Michael
    Sprenkle, Preston
    JOURNAL OF UROLOGY, 2018, 199 (04): : E209 - E209
  • [50] Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
    Tomer, Anirudh
    Nieboer, Daan
    Roobol, Monique J.
    Bjartell, Anders
    Steyerberg, Ewout W.
    Rizopoulos, Dimitris
    BJU INTERNATIONAL, 2021, 127 (01) : 96 - 107
12345